Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl4

Table 1 Serum function tests

	n	LT (U/L)	AST (U/L)
Control	10	99.50 ± 18.78	244.50 ± 46.52
Model	7	1863.29 ± 893.68a	2680.00 ± 1039.12a
Losartan (20 mg/kg)	7	432.14 ± 112.26d	824.57 ± 265.41d
Losartan (10 mg/kg)	7	535.25 ± 200.78d	77.50 ± 270.32d
Losartan (5 mg/kg)	6	771.71 ± 237.18c	1643.00 ± 810.36

^aP < 0.05 vs control;

^cP < 0.05 vs model;

^dP < 0.01 vs model